Robeaute
Developer of a microrobotic platform intended to access, sample, deliver therapeutics, stimulate and monitor the brain via millimetre- and sub-millimetre-scale robots and supporting surgical infrastructure. The organisation focuses on microfabrication and micro-assembly of miniature propulsion, steering and tracking components, integration with imaging and neuronavigation, preclinical validation, regulatory engagement for first-in-human studies, and software for real-time control and data capture.
Industries
Nr. of Employees
small (1-50)
Patents
Position tracking system for tracking an internal device during an imaging
US-12433504-B2
View Details
Position tracking system for tracking an internal device during an imaging
US-12433504-B2
View DetailsProducts
Microrobotic platform (microrobot, deployment system, surgical console)
A modular system comprising millimetre-scale robots, a launcher for deployment/retrieval, and a surgical console that integrates imaging, planning and real-time tracking to enable targeted diagnosis, local therapy delivery and monitoring.
Dot
Proprietary multi-purpose microrobot designed to navigate the intricate pathways of brain tissue to deliver tools and therapeutics spatially to hard-to-reach areas of the brain.
Dot.Drug
Flexible microdelivery system designed to carry and drop therapeutic cargo precisely where it is needed.
Dot.Biopsy
Smart biopsy device aiming to provide multiple spatially anatomo-localised biopsies to nurture personalised treatment decisions.
Dot.Electrode
New generation electrode designed to converse with the brain for smart electrode-based stimulation to treat symptoms such as Parkinson's disease or treatment-resistant depression.
CAP
Launcher for robot deployment and retrieval, enabling real-time sub-millimetric tracking and seamless communication between Dot and MOM.
Microrobotic platform (microrobot, deployment system, surgical console)
A modular system comprising millimetre-scale robots, a launcher for deployment/retrieval, and a surgical console that integrates imaging, planning and real-time tracking to enable targeted diagnosis, local therapy delivery and monitoring.
Dot
Proprietary multi-purpose microrobot designed to navigate the intricate pathways of brain tissue to deliver tools and therapeutics spatially to hard-to-reach areas of the brain.
Dot.Drug
Flexible microdelivery system designed to carry and drop therapeutic cargo precisely where it is needed.
Dot.Biopsy
Smart biopsy device aiming to provide multiple spatially anatomo-localised biopsies to nurture personalised treatment decisions.
Dot.Electrode
New generation electrode designed to converse with the brain for smart electrode-based stimulation to treat symptoms such as Parkinson's disease or treatment-resistant depression.
CAP
Launcher for robot deployment and retrieval, enabling real-time sub-millimetric tracking and seamless communication between Dot and MOM.
Services
Preclinical ex-vivo and animal studies to evaluate navigation, payload deployment and targeted delivery prior to clinical translation.
Preclinical ex-vivo and animal studies to evaluate navigation, payload deployment and targeted delivery prior to clinical translation.
Expertise Areas
- Microrobotics for neurosurgery
- Microfabrication and micro-assembly
- Neuronavigation and surgical navigation systems
- Targeted local drug delivery
Key Technologies
- Microrobotics
- Micro-propulsion mechanisms
- Miniature steering mechanisms
- Sub-millimetre localisation and tracking
News & Updates
Preclinical study reporting neuronavigated local solid drug delivery using a microrobotic system.
Ex-vivo validation study of 3D neuronavigation using a neurosurgical microrobot.
Technical publication on estimating MRI registration error using a regression U-Net approach; authored by company-affiliated researchers.
Announcement describing a $28M funding round to accelerate development and clinical translation of a microrobotic platform for brain interventions.
Selection into a technology pioneers programme highlighting the company's microrobotic platform as an innovation in medical robotics.
Raised $28 million in a Series A round to accelerate development and clinical translation.
Preclinical study reporting neuronavigated local solid drug delivery using a microrobotic system.
Ex-vivo validation study of 3D neuronavigation using a neurosurgical microrobot.
Technical publication on estimating MRI registration error using a regression U-Net approach; authored by company-affiliated researchers.
Announcement describing a $28M funding round to accelerate development and clinical translation of a microrobotic platform for brain interventions.
Selection into a technology pioneers programme highlighting the company's microrobotic platform as an innovation in medical robotics.
Raised $28 million in a Series A round to accelerate development and clinical translation.